|
1
|
Torre LA, Bray F, Siegel RL, Ferlay J,
Lortet-Tieulent J and Jemal A: Global cancer statistics, 2012.
Cancer J Clin. 65:87–108. 2015. View Article : Google Scholar
|
|
2
|
Siegel RL, Miller KD and Jemal A: Cancer
statistics, 2015. CA Cancer J Clin. 65:5–29. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Molina JR, Yang P, Cassivi SD, Schild SE
and Adjei AA: Non-small cell lung cancer: Epidemiology, risk
factors, treatment, and survivorship. Mayo Clin Proc. 83:584–594.
2008. View
Article : Google Scholar : PubMed/NCBI
|
|
4
|
Gupta GP and Massagué J: Cancer
metastasis: Building a framework. Cell. 127:679–695. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Sun L, Li J and Yan B: Gene expression
profiling analysis of osteosarcoma cell lines. Mol Med Rep.
12:4266–4272. 2015.PubMed/NCBI
|
|
6
|
Huang HL, Wu YC, Su LJ, Huang YJ,
Charoenkwan P, Chen WL, Lee HC, Chu WC and Ho SY: Discovery of
prognostic biomarkers for predicting lung cancer metastasis using
microarray and survival data. BMC Bioinformatics. 16:542015.
View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Jia DS, Yan M, Wang X, Hao X, Liang L, Liu
L, Kong H, He X, Li J and Yao M: Development of a highly metastatic
model that reveals a crucial role of fibronectin in lung cancer
cell migration and invasion. BMC Cancer. 10:3642010. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Morandi L, de Biase D, Visani M, Monzoni
A, Tosi A, Brulatti M, Turchetti D, Baccarini P, Tallini G and
Pession A: T([20]) repeat in the 3′-untranslated region of the MT1X
gene: A marker with high sensitivity and specificity to detect
microsatellite instability in colorectal cancer. Int J Colorectal
Dis. 27:647–656. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Peng B, Gu Y, Xiong Y, Zheng G and He Z:
Microarray-assisted pathway analysis identifies MT1X & NFκB as
mediators of TCRP1-associated resistance to cisplatin in oral
squamous cell carcinoma. PLoS One. 7:e514132012. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Huang da W, Sherman BT and Lempicki RA:
Systematic and integrative analysis of large gene lists using DAVID
bioinfor-matics resources. Nat Protoc. 4:44–57. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Harris MA, Clark J, Ireland A, Lomax J,
Ashburner M, Foulger R, Eilbeck K, Lewis S, Marshall B, Mungall C,
et al: The gene ontology (GO) database and informatics resource.
Nucleic Acids Res. 32:(Database issue). D258–D261. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(−Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Siddiqui N and Borden KL: mRNA export and
cancer. Wiley Interdiscip Rev RNA. 3:13–25. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Hajingabo LJ, Daakour S, Martin M,
Grausenburger R, Panzer-Grümayer R, Dequiedt F, Simonis N and
Twizere JC: Predicting interactome network perturbations in human
cancer: Application to gene fusions in acute lymphoblastic
leukemia. Mol Biol Cell. 25:3973–3985. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Zhang Y, Yu JJ, Tian Y, Li ZZ, Zhang CY,
Zhang SF, Cao LQ, Zhang Y, Qian CY, Zhang W, et al: eIF3a improve
cisplatin sensitivity in ovarian cancer by regulating XPC and
p27Kip1 translation. Oncotarget. 6:25441–25451. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Spilka R, Ernst C, Bergler H, Rainer J,
Flechsig S, Vogetseder A, Lederer E, Benesch M, Brunner A, Geley S,
et al: eIF3a is over-expressed in urinary bladder cancer and
influences its phenotype independent of translation initiation.
Cell Oncol (Dordr). 37:253–267. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Shen J, Yin JY, Li XP, Liu ZQ, Wang Y,
Chen J, Qu J, Xu XJ, McLeod HL, He YJ, et al: The prognostic value
of altered eIF3a and its association with p27 in non-small cell
lung cancers. PLoS One. 9:e960082014. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Marchione R, Laurin D, Liguori L,
Leibovitch MP, Leibovitch SA and Lenormand JL: MD11-mediated
delivery of recombinant eIF3f induces melanoma and colorectal
carcinoma cell death. Mol Ther Methods Clin Dev. 2:140562015.
View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Wen F, Zhou R, Shen A, Choi A, Uribe D and
Shi J: The tumor suppressive role of eIF3f and its function in
translation inhibition and rRNA degradation. PLoS One.
7:e341942012. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Wang H, Ru Y, Sanchez-Carbayo M, Wang X,
Kieft JS and Theodorescu D: Translation initiation factor eIF3b
expression in human cancer and its role in tumor growth and lung
colonization. Clin Cancer Res. 19:2850–2860. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Do SI, Kim YW, Park HR and Park YK:
Expression of insulin-like growth factor-II mRNA binding protein 3
(IMP3) in osteosarcoma. Oncol Res. 17:269–272. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Jiang Z, Lohse CM, Chu PG, Wu CL, Woda BA,
Rock KL and Kwon ED: Oncofetal protein IMP3: A novel molecular
marker that predicts metastasis of papillary and chromophobe renal
cell carcinomas. Cancer. 112:2676–2682. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Miyamoto T, Asaka R, Suzuki A, Takatsu A,
Kashima H and Shiozawa T: Immunohistochemical detection of a
specific receptor for lipocalin2 (solute carrier family 22 member
17, SLC22A17) and its prognostic significance in endometrial
carcinoma. Exp Mol Pathol. 91:563–568. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Aharinejad S, Salama M, Paulus P, Zins K,
Berger A and Singer CF: Elevated CSF1 serum concentration predicts
poor overall survival in women with early breast cancer. Endocr
Relat Cancer. 20:777–783. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Liu X, Ma D, Jing X, Wang B, Yang W and
Qiu W: Overexpression of ANXA2 predicts adverse outcomes of
patients with malignant tumors: A systematic review and
meta-analysis. Med Oncol. 32:3922015. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Wan J, Che Y, Kang N and Wu W: SOCS3
blocks HIF-1α expression to inhibit proliferation and angiogenesis
of human small cell lung cancer by downregulating activation of
Akt, but not STAT3. Mol Med Rep. 12:83–92. 2015.PubMed/NCBI
|
|
27
|
Chien MH, Lee WJ, Hsieh FK, Li CF, Cheng
TY, Wang MY, Chen JS, Chow JM, Jan YH, Hsiao M, et al: Keap1-Nrf2
interaction suppresses cell motility in lung adenocarcinomas by
targeting the S100P protein. Clin Cancer Res. 21:4719–4732. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Lococo F, Paci M, Rapicetta C, Rossi T,
Sancisi V, Braglia L, Cavuto S, Bisagni A, Bongarzone I, Noonan DM,
et al: Preliminary evidence on the diagnostic and molecular role of
circulating soluble EGFR in non-small cell lung cancer. Int J Mol
Sci. 16:19612–19630. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Bulk E, Sargin B, Krug U, Hascher A, Jun
Y, Knop M, Kerkhoff C, Gerke V, Liersch R, Mesters RM, et al:
S100A2 induces metastasis in non-small cell lung cancer. Clin
Cancer Res. 15:22–29. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Li S, Tian H, Yue W, Li L, Gao C, Si L, Li
W, Hu W, Qi L and Lu M: Down-regulation of MTA1 protein leads to
the inhibition of migration, invasion, and angiogenesis of
non-small-cell lung cancer cell line. Acta Biochim Biophys Sin
(Shanghai). 45:115–122. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Zhu X, Zhang X, Wang H, Song Q, Zhang G,
Yang L, Geng J, Li X, Yuan Y and Chen L: MTA1 gene silencing
inhibits invasion and alters the microRNA expression profile of
human lung cancer cells. Oncol Rep. 28:218–224. 2012.PubMed/NCBI
|
|
32
|
Li L, Liu D, Qiu ZX, Zhao S, Zhang L and
Li WM: The prognostic role of mTOR and p-mTOR for survival in
non-small cell lung cancer: A systematic review and meta-analysis.
PLoS One. 10:e01167712015. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Liu J, Cho SN, Akkanti B, Jin N, Mao J,
Long W, Chen T, Zhang Y, Tang X, Wistub II, et al: ErbB2 pathway
activation upon Smad4 Loss promotes lung tumor growth and
metastasis. Cell Rep. pii:S2211–S1247. 2015.
|
|
34
|
McCorkle JR, Leonard MK, Kraner SD,
Blalock EM, Ma D, Zimmer SG and Kaetzel DM: The metastasis
suppressor NME1 regulates expression of genes linked to metastasis
and patient outcome in melanoma and breast carcinoma. Cancer
Genomics Proteomics. 11:175–194. 2014.PubMed/NCBI
|
|
35
|
Yu T, Li J, Yan M, Liu L, Lin H, Zhao F,
Sun L, Zhang Y, Cui Y, Zhang F, et al: MicroRNA-193a-3p and −5p
suppress the metastasis of human non-small-cell lung cancer by
downregulating the ERBB4/PIK3R3/mTOR/S6K2 signaling pathway.
Oncogene. 34:413–423. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Yu T, Liu L, Li J, Yan M, Lin H, Liu Y,
Chu D, Tu H, Gu A and Yao M: miRNA-10a is upregulated in NSCLC and
may promote cancer by targeting PTEN. Oncotarget. 6:30239–30250.
2015.PubMed/NCBI
|
|
37
|
Talsma K, van Hagen P, Grotenhuis BA,
Steyerberg EW, Tilanus HW, van Lanschot JJ and Wijnhoven BP:
Comparison of the 6th and 7th Editions of the UICC-AJCC TNM
Classification for Esophageal Cancer. Annals of Surgical Oncology.
July;2012.19(7): 2142–2148. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Györffy B, Lanczky A, Eklund AC, Denkert
C, Budczies J, Li Q and Szallasi Z: An online survival analysis
tool to rapidly assess the effect of 22,277 genes on breast cancer
prognosis using microarray data of 1,809 patients. Breast Cancer
Res Treat. 123:725–731. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Győrffy B, Surowiak P, Budczies J and
Lánczky A: Online survival analysis software to assess the
prognostic value of biomarkers using transcriptomic data in
non-small-cell lung cancer. PLoS One. 8:e822412013. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Shankar J and Nabi IR: RNA purification
from tumor cell protrusions using porous polycarbonate filters.
Methods Mol Biol. 714:353–366. 2011. View Article : Google Scholar : PubMed/NCBI
|
